Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function

Circulation

Volumn 100, Issue 19, 1999, Pages 1992-2002

  Kim, Raymond J ^a,b   Fieno, David S ^a,b   Parrish, Todd B ^a,b   Harris, Kathleen ^a   Chen, Enn Ling ^a   Simonetti, Orlando ^c   Bundy, Jeffrey ^c   Finn, J Paul ^a,b   Klocke, Francis J ^a,b   Judd, Robert M ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Department of Medicine ^*  (United States)

^c SIEMENS CORPORATE RESEARCH   (United States)

Author keywords

Ischemia; Magnetic resonance imaging; Myocardial infarction

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOG; DOPPLER FLOWMETRY; HEART INFARCTION; IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0033539584     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.19.1992     Document Type: Article

References (33)

1. Gersh BJ, Anderson JL. Thrombolysis and myocardial salvage: results of clinical trials and the animal paradigm. Circulation. 1993;88:296-306.
2. Atkinson DJ, Butstein D, Edelman RR. First-pass cardiac perfusion evaluation with ultrafast MR imaging. Radiology. 1990;174:757-762.
3. Wilke N, Simm C, Zhang J, Ellerman J, Ya X, Merkle H, Path G, Ludemann H, Bache RJ, Ugurbil K. Contrast-enhanced first pass myocardial-perfusion imaging. Magn Reson Med. 1993;29:485-497.
4. Lima JAC, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Circulation. 1995;92:1117-1125.
5. Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Croisille P, Lima JAC, Mohan V, Becker LC, Zerhouni EA. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation. 1995;92:1902-1910.
6. McNamara MT, Tscholakoff D, Revel D, Soulen R, Schechtmann N, Botvinick E, Higgins CB. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. Radiology. 1986;158:765-769.
7. Schaefer S, Malloy CR, Katz J, Parkey RW, Buja LM, Willerson JT, Peshock RM. Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium. J Am Coll Cardiol. 1988;12: 1064-1072.
8. Saeed M, Wendland MF, Takehara Y, Masui T, Higgins CB. Reperfusion and irreversible myocardial injury. Radiology. 1992;182:675-683.
9. Peshock RM, Malloy CR, Buja LM, Nunnally RL, Parkey RW, Willerson JT. Magnetic resonance imaging of acute myocardial infarction. Circulation. 1986;74:1434-1440.
10. Van Rossum AC, Visser FC, Van Eenige MJ, Sprenger M, Valk J, Verheugt FW, Roos JP. Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis. Am J Cardiol. 1990;65:845-851.
11. van der Wall EE, van Dijkman PRM, de Roos A, Doombos J, van der Laarse A, Manger Cats V, van Voorthuisen AE, Matheijssen NAA, Bruschke AVG. Diagnostic significance of gadolinium-DTPA (diethylenetriamine penta-acetic acid) enhanced magnetic resonance imaging in thrombolytic therapy for acute myocardial infarction. Br Heart J. 1990; 63:12-17.
12. de Roos A, van Rossum AC, van der Wall EE, Postema S, Doornbos J, Matheijssen NAA, van Dijkman PRM, Visser FC, van Voorthuisen AE. Reperfused and nonreperfused myocardial infarction. Radiology. 1989; 172:717-720.
13. Rehr RB, Peshock RM, Malloy CR, Keller AM, Parkey RW, Buja LM, Nunnally RL, Willerson JT. Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration. Am J Cardiol. 1986;57:864-868.
14. Nishimura T, Yamada Y, Hayashi M, Kozuka T, Nakatani T, Noda H, Takano H. Determination of infarct size of acute myocardial infarction in dogs by magnetic resonance imaging and gadolinium-DTPA. Am J Physiol Imaging. 1989;4:83-88.
15. Wesby GE, Higgins CB, McNamara MT, Engelstad BL, Lipton MJ, Sievers R, Ehman RL, Lovin J, Brasch RC. Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. Radiology. 1984;153:165-169.
16. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, Blumenthal RS, Lima JAC. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765-772.
17. Whalen DA Jr, Hamilton DG, Ganote CE, Jennings RB. Effect of a transient period of ischemia on myocardial cells. Am J Pathol. 1974;74: 381-398.
18. Jennings RB, Schaper J, Hill ML, Steenbergen C Jr, Reimer KA. Effect of reperfusion late in the phase of reversible ischemic injury. Circ Res. 1985;56:262-278.
19. van Rugge FP, van der Wall EE, Spanjersberg SJ, de Roos A, Matheijssen NAA, Zwinderman AH, van Dijkman PRM, Reiber JHC, Bruschke AVG. Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Circulation. 1994;90:127-138.
20. Masui T, Saeed M, Wendland MF, Higgins CB. Occlusive and reperfused myocardial infarcts: MR imaging differentiation with nonionic Gd-DTPA-BMA. Radiology. 1991;181:77-83.
21. Baer FM, Theissen P, Schneider CA, Voth E, Schicha H, Sechtem U. Magnetic resonance tomography imaging techniques for diagnosing myocardial vitality. Herz. 1994;19:51-64.
22. Goldman MR, Brady TJ, Pykett IL, Burt CT, Buonanno FS, Kistler P, Newhouse JH, Hinshaw WS, Pohost GM. Quantification of experimental myocardial infarction using nuclear magnetic resonance imaging and paramagnetic ion contrast enhancement in excised canine hearts. Circulation. 1982;66:1012-1016.
23. Kim RJ, Chen E-L, Lima JAC, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation. 1996; 94:3318-3326.
24. Weinmann HJ, Laniado M, Mutzel W. Pharmacokinetics of Gd-DTPA-dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys. 1984;16:167-172.
25. Steenbergen C, Hill ML, Jennings RB. Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro. Circ Res. 1985;57:864-875.
26. Jennings RB, Steenbergen C Jr, Kinney RB, Hill ML, Reimer KA. Comparison of the effect of ischaemia and anoxia on the sarcolemma of the dog heart. Eur Heart J. 1983;4(suppl H):123-137.
27. Ramani K, Judd RM, Holly TA, Parrish TB, Rigolin VH, Parker MA, Callahan C, Fitzgerald SW, Bonow RO, Klocke FJ. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. Circulation. 1998;98:2687-2694.
28. Fedele F, Montesano T, Ferro-Luzzi M, Di Cesare E, Di Renzi P, Scopinaro F, Agati L, Penco M, Serri F, Vitarelli A, Dagianti A. Identification of viable myocardium in patients with chronic coronary artery disease. Am Heart J. 1994;128:484-489.
29. Eichstaedt HW, Felix R, Dougherty FC, Langer M, Rutsch W, Schmutzler H. Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium-DTPA. Clin Cardiol. 1986;9:527-535.
30. Nishimura T, Kobayashi H, Ohara Y, Yamada N, Haze K, Takamiya M, Hiramori K. Serial assessment of myocardial infarction by using gated MR imaging and Gd-DTPA. AJR Am J Roentgenol. 1989;153:715-720.
31. Van Dijkman PRM, van der Wall EE, de Roos A, Matheijssen NAA, van Rossum AC, Doombos J, van der Laarse A, van Voorthuisen AE, Bruschke AVG. Acute, subacute and chronic myocardial infarction: quantitative analysis of gadolinium-enhanced MR images. Radiology. 1991;180:147-151.
32. Reimer KA, Jennings RB. The changing anatomic reference base of evolving myocardial infarction. Circulation. 1979;60:866-876.
33. Reimer KA, Jennings RB. Myocardial Ischemia, Hypoxia, and Infarction. New York, NY: Raven Press Ltd; 1992:1875-1973.